Evidence map›Paper›PMID 15580338›Full record

ArticleExperimental brain research2005

Selective subunit antagonists suggest an inhibitory relationship between NR2B and NR2A-subunit containing N-methyl-D: -aspartate receptors in hippocampal slices.

Andrew P Mallon, Yves P Auberson, Trevor W Stone

Abstract read
PubMed Publisher
In one paragraph

Article in Experimental brain research, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Growth hormone and cognitive function.Nature reviews. Endocrinology · 2013
    Review
  7. Article
  8. Article
  9. Activation of NR2A receptors induces ischemic tolerance through CREB signaling.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2010
    Article
  10. Modulation of glutamatergic synaptic transmission in the bed nucleus of the stria terminalis.Progress in neuro-psychopharmacology & biological psychiatry · 2009
    Review
  11. Alcohol inhibits NR2B-containing NMDA receptors in the ventral bed nucleus of the stria terminalis.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2008
    Article
  12. Article
  13. Review
  14. Article
  15. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2007
    Article
  16. Estradiol-induced increase in the magnitude of long-term potentiation is prevented by blocking NR2B-containing receptors.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2006
    Article
  17. NMDA receptor NR2 subunit dependence of the slow component of magnesium unblock.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2006
    Article
  18. Activation of NR2A-containing NMDA receptors is not obligatory for NMDA receptor-dependent long-term potentiation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2005
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 3 countries.

Andrew P MallonInstitute of Biomedical & Life Sciences, Division of Neuroscience and Biomedical Systems, West Medical Building, University of Glasgow, Glasgow,
Yves P Auberson
Trevor W Stone
University of Glasgow · GBNovartis (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glutamate receptors responding to N-methyl-D: -aspartate (NMDA) are involved in neural development, excitotoxicity and neuronal plasticity. Each receptor includes at least two NR2 subunits. Here, we have examined the effects of selective antagonists of NR2A and NR2B subunits (NVP-AAM07 and Ro25-6981 respectively) on the effects of NMDA in the CA1 field of rat hippocampal slices. We have observed that Ro25-6981 potentiates, rather than blocks, the effects of NMD on field EPSPs and paired-pulse interactions (indicators of presynaptic effects) and on postsynaptic depolarisation in hippocampal slices. The NR2A subunit antagonist NVP-AAM077 blocks the effects of NMDA alone, or after potentiation by Ro25-6981. The potentiation of NMDA by Ro25-6981 was not prevented by staurosporine (protein kinase inhibitor), okadaic acid (an inhibitor of serine/threonine protein phosphatases) or anisomycin (protein synthesis inhibitor), but was prevented by cyclosporin A, which inhibits Ca2+/calmodulin-dependent phosphatase 2B [calcineurin]. NMDA-dependent long-term potentiation (LTP) induced by electrical stimulation was not prevented by Ro25-6981 but was prevented by selective blockade of the NR2A subunit. The results suggest that, at both presynaptic and postsynaptic sites in the rat hippocampus, NR2B-subunit-containing receptors limit NMDA receptor function by inhibitory restraint over NR2A-subunit-containing receptors, via calcineurin activation, and that LTP induction critically involves primarily receptors containing the NR2A subunit. Endogenous factors or drugs that modify this NR2B/NR2A interaction could have a major influence on synaptic transmission and plasticity in the brain.

Indexed as

AnimalsCalcineurinCalcineurin InhibitorsEnzyme InhibitorsExcitatory Amino Acid AntagonistsExcitatory Postsynaptic PotentialsHippocampusLong-Term PotentiationMaleNeural InhibitionOrgan Culture TechniquesPhenolsPiperidinesProtein Synthesis InhibitorsQuinoxalinesRats5-(alpha-methyl-4-bromobenzylamino)phosphonomethyl-1,4-dihydroquinoxaline-2,3-dioneCalcineurinCalcineurin InhibitorsEnzyme InhibitorsExcitatory Amino Acid AntagonistsNR2A NMDA receptorNR2B NMDA receptorPhenolsPiperidinesProtein Synthesis InhibitorsQuinoxalinesReceptors, N-Methyl-D-AspartateRo 25-6981

Identifiers

PMID15580338
OpenAlexW1999239325

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.